Author(s):
T.G. Rukari, P.A. Gavali, V.J. Patil, S.S. Gaonakr, K.S. Rathod, Y.M. Patil, Y.R. Dhongade, V.A. Jagtap
Email(s):
tushar.rukari@gmail.com
DOI:
10.52711/2231-5713.2024.00052 
Address:
T.G. Rukari*, P.A. Gavali, V.J. Patil, S.S. Gaonakr, K.S. Rathod, Y.M. Patil, Y.R. Dhongade, V.A. Jagtap
Yashwantrao Bhonsale College of Pharmacy, Sawantwadi.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2024
ABSTRACT:
Inflammation is a complex physiological response involved in numerous pathological conditions, requiring effective treatment. Non-steroidal anti-inflammatory drugs (NSAIDs) have long been utilized to alleviate inflammation associated symptoms. Conventional topical formulations of NSAID suffer from limitations such as poor skin penetration, low drug retention, and inadequate therapeutic efficacy. To overcome this limitations, novel vesicular drug delivery systems, particularly transferosomes, have emerged as promising alternatives. Transferosomes, a specialized type of deformable liposomes, offers unique advantage for targeted drug delivery through the skin. They can deform and squeeze through narrow intercellular spaces, enhancing drug permeation into underlying tissues. This facilitates deepest penetration of NSAIDs into inflamed regions, maximizing therapeutic effects while minimizing systemic exposure and adverse effects. Transferosomes, formed via thin film hydration method with oleic acid, cholesterol, surfactant, and organic solvent. They have a particle size of 297nm and a mean zeta potential of -24.2mV. Entrapment efficiency is 83% and demonstrates effective drug retention. The optimized batch is chosen on particle size and entrapment efficiency, and these incorporated into carbopol 934 gel and evaluated for appearance, grittiness, texture pH, spreadability, extrudability, drug content and in-vitro drug release. This comprehension evaluation ensures formulation efficiency. Overall, the development and evaluation of novel vesicular drug delivery systems, particularly transferosomes, represent significant advancement in drug delivery technology. By utilizing their unique properties, these systems hold promise for improving therapeutic efficacy and enabling sustain release in the treatment of inflammatory conditions.
Cite this article:
T.G. Rukari, P.A. Gavali, V.J. Patil, S.S. Gaonakr, K.S. Rathod, Y.M. Patil, Y.R. Dhongade, V.A. Jagtap. Innovative Vesicular Drug Delivery System of Ibuprofen with Unsaturated Fatty Acids: Formulation and Evaluation. Asian Journal of Pharmacy and Technology. 2024; 14(4):319-4. doi: 10.52711/2231-5713.2024.00052
Cite(Electronic):
T.G. Rukari, P.A. Gavali, V.J. Patil, S.S. Gaonakr, K.S. Rathod, Y.M. Patil, Y.R. Dhongade, V.A. Jagtap. Innovative Vesicular Drug Delivery System of Ibuprofen with Unsaturated Fatty Acids: Formulation and Evaluation. Asian Journal of Pharmacy and Technology. 2024; 14(4):319-4. doi: 10.52711/2231-5713.2024.00052 Available on: https://ajptonline.com/AbstractView.aspx?PID=2024-14-4-5
REFERENCES:
1. Abdelbari MA, Elshafeey AH, Abdelbary AA, Mosallam S. Implementing Nanovesicles for Boosting the Skin Permeation of Non-steroidal Anti-inflammatory Drugs. AAPS PharmSciTech. 2023; Sep 28; 24(7): 195.
2. Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Controlled Release. 2020; Nov 10; 327: 641–66.
3. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; Oct 1; 180: 114147.
4. Pham CV, Van MC, Thi HP, Thanh CĐ, Ngoc BT, Van BN, et al. Development of ibuprofen-loaded solid lipid nanoparticle-based hydrogels for enhanced in vitro dermal permeation and in vivo topical anti-inflammatory activity. J Drug Deliv Sci Technol. 2020; Jun 1; 57: 101758.
5. Amirinejad M, Davoodi J, Abbaspour MR, Akhgari A, Hadizadeh F, Badiee A. Preparation, characterization and improved release profile of ibuprofen-phospholipid association. J Drug Deliv Sci Technol. 2020; Dec 1; 60: 101951.
6. Pandey P, Pancholi SS. Nanocarrier based transdermal formulation of NSAID: Optimization of drug loading and analysis of permeation characteristics. 2016;3.
7. Tushar Rukari, Prashant Pingale, Chandrashekhar Upasani. Vesicular drug delivery systems for the fungal infections’ treatment through topical application-a systemic review. J Curr Sci Technol. 2023; Jul 24;13(2):500–16.
8. Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery. Pharmaceutics. 2020 Sep;12(9):855.
9. Verma S, Bhardwaj A, Vij M, Bajpai P, Goutam N, Kumar L. Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Artif Cells Nanomedicine Biotechnol. 2014 Apr 1; 42(2): 95–101.
10. Priyanka BA, Hrushikesh JA. Phase solubility studies of ibuprofen with beta-cyclodextrin and hydroxy propyl-beta cyclodextrin in different buffer media. Indo Am J Pharm Sci. 2017;4(8):2386–92.
11. Divya R, Hariharan G, Tamilarasan R, Indhumathi P. Design and Development of Ibuprofen Loaded Transferosomal Gel for Analgesic Activity. 2023; Aug 3; 12: 2023.
12. Sharma U, VERMA P, Jain N. A Review on Novel Vesicular Drug Delivery System: Transfersomes. 2020; Jul 1; 11: 6812–24.
13. Giri MA, Abhale AC, Ahire MR, Bhalke RD. Formulation, Characterization, and Evaluation of Topical Anti-inflammatory. 10(3).
14. Kashyap A, Das A, Ahmed A. Formulation and Evaluation of Transdermal Topical Gel of Ibuprofen. J Drug Deliv Ther. 2020; Mar 15; 10: 20–5.
15. Jagdale S, Pawar S. Gellified Emulsion of Ofloxacin for Transdermal Drug Delivery System. Adv Pharm Bull. 2017; Jun; 7(2): 229–39.
16. Yameen SH, Shahidulla SM. Formulation and evaluation of Lamivudine transferosomal gel. J Drug Deliv Ther. 2022; Nov 20; 12(4-S): 163–70.